// App-Quantinova.ai

10036 : Alfa-feto protein (AFP) as a predictor of outcome for children with germ cell tumors: A report from the malignant germ cell international consortium.

Researchers

Presenter

  • Allison Frances O'Neill

Principal Investigators

  • Caihong Xia

  • Mark D. Krailo

  • Furqan Shaikh

  • Farzana D. Pashankar

  • Deborah F Billmire

  • Thomas Arthur Olson

  • James F. Amatruda

  • Doojduen Villaluna

  • Marcio H. Malogolowkin

  • Carlos Rodriguez-Galindo

  • A. Lindsay Frazier

Medical Centers

  • Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorder Center, Boston, MA

  • UCLA, Los Angeles, CA

  • Children's Oncology Group, Monrovia, CA

  • Hospital for Sick Children, Toronto, ON, Canada

  • Yale Cancer Center, Yale School of Medicine, New Haven, CT

  • Riley Hospital for Children, Indianapolis, IN

  • Emory University and Children's Healthcare of Atlanta, Atlanta, GA

  • Massachusetts General Hospital, Boston, MA

  • Children's Oncology Group, Monrovia, CA

  • University of California, Davis School of Medicine, Sacramento, CA

  • St. Jude Children's Research Hospital, Boston, MA

  • Dana-Farber Cancer Institute, Boston, MA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Alpha-fetoprotein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved